# Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI

> **NCT03822975** · NA · COMPLETED · sponsor: **Shenyang Northern Hospital** · enrollment: 6016 (actual)

## Conditions studied

- ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Bivalirudin
- **DRUG:** unfractionated Heparin

## Key facts

- **NCT ID:** NCT03822975
- **Lead sponsor:** Shenyang Northern Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-14
- **Primary completion:** 2022-05-07
- **Final completion:** 2023-05-06
- **Target enrollment:** 6016 (ACTUAL)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03822975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03822975, "Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03822975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*